Journal of Clinical Oncology, Vol 1, 645-651, Copyright © 1983 by American Society of Clinical Oncology
Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary
RW Carlson, BI Sikic, MM Turbow and SC Ballon
Nine women with germ-cell tumors of the ovary (three endodermal sinus
tumors, four immature teratomas, and two mixed germ-cell tumors) were
treated with cisplatin, vinblastine, and bleomycin (PVB) chemotherapy after
cytoreductive operations. Five patients were stage I, three were stage III,
and one patient had recurrent disease. All nine women are alive and without
evidence of disease with a median follow-up of 31 months from diagnosis and
27 months since completion of PVB. Treatment toxicity although occasionally
severe was rapidly reversible.
This article has been cited by other articles:
|
|
|
|
 
D. M. Gershenson, A. M. Miller, V. L. Champion, P. O. Monahan, Q. Zhao, D. Cella, and S. D. Williams
Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study
J. Clin. Oncol.,
July 1, 2007;
25(19):
2792 - 2797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. C. Rogers, T. A. Olson, J. W. Cullen, D. F. Billmire, N. Marina, F. Rescorla, M. M. Davis, W. B. London, S. J. Lauer, R. H. Giller, et al.
Treatment of Children and Adolescents With Stage II Testicular and Stages I and II Ovarian Malignant Germ Cell Tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891
J. Clin. Oncol.,
September 1, 2004;
22(17):
3563 - 3569.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Cushing, R. Giller, J. W. Cullen, N. M. Marina, S. J. Lauer, T. A. Olson, P. C. Rogers, P. Colombani, F. Rescorla, D. F. Billmire, et al.
Randomized Comparison of Combination Chemotherapy With Etoposide, Bleomycin, and Either High-Dose or Standard-Dose Cisplatin in Children and Adolescents With High-Risk Malignant Germ Cell Tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882
J. Clin. Oncol.,
July 1, 2004;
22(13):
2691 - 2700.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-C. J. Yeung, A. C. Chiu, R. Vassilopoulou-Sellin, and R. F. Gagel
The Endocrine Effects of Nonhormonal Antineoplastic Therapy
Endocr. Rev.,
April 1, 1998;
19(2):
144 - 172.
[Abstract]
[Full Text]
|
|
|
|
